SCHEMBL24623815

SCHEMBL24623815

c1cnc2c(c1)oc1cc(-c3cnc4c(c3)oc3ccncc34)cnc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 1/20 0.39
▸ CLK1 P49759 3/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ MAPT P10636 5/20 0.38
▸ MAPK10 P53779 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NPC1 O15118 4/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MET P08581 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ CYP2A6 P11509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11885009 0.87 MAPK14 (0.42) MAPK14MAPTKDM4EMEN1KMT2A
SCHEMBL25463813 0.87 MAPT (0.34) ACVR1CLK1MAPK14MAPTKDM4E
SCHEMBL21157144 0.84 CLK1 (0.39) ACVR1CLK1MAPK14MAPTMEN1
SCHEMBL24623671 0.81 MAPT (0.39) ACVR1CLK1MAPTMAPK10KDM4E
SCHEMBL24624433 0.79 MAPK14 (0.34) ACVR1MAPK14MAPTCYP2A6
SCHEMBL18575923 0.78 PGR (0.33) CLK1MAPK14CYP19A1
SCHEMBL15835978 0.78 PGR (0.40) MAPK14MAPTKDM4ENPC1L3MBTL1
SCHEMBL15855249 0.78 PGR (0.40) MAPK14MAPTKDM4ENPC1L3MBTL1
SCHEMBL15836024 0.78 PGR (0.40) MAPK14MAPTKDM4ENPC1L3MBTL1
SCHEMBL25463810 0.77 KMT2A (0.35) ACVR1CLK1MAPTMAPK10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF NR0B2, FPR3, NPR3 ACVR1 552/4885CLK1 2296/4885MAPK14 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback